ERAXIS
LOE Approachinganidulafungin
NDAINTRAVENOUSPOWDER
Approved
Feb 2006
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Mechanism of Action
anti-fungal drug [see ].
Pharmacologic Class:
Echinocandin Antifungal
Clinical Trials (5)
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis® IV
Started Mar 2012
244 enrolled
CandidemiaOther Forms of Candida Infections(Intra-abdominal Abscess, Peritonitis)
Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients
Started Nov 2011
61 enrolled
Liver DiseaseFungal Infection
Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom
Started Feb 2011
50 enrolled
Candidiasis
A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis
Started Dec 2010
17 enrolled
Candidemia
Anidulafungin in Patients With Hematologic Malignancies
Started Oct 2009
10 enrolled
Hematologic Malignancies